Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus

Nikolett Nagy, Bernadett Bói, Gábor Papp, Edit Fiák, Eszter Gáspár-Kiss, Bianka Perge, Nikolett Farmasi, Tünde Tarr

Open source

DOI
10.3390/biomedicines12030530
Published
2024-02-27
Container
Biomedicines
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines12030530,
  title = {Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus},
  author = {Nikolett Nagy and Bernadett Bói and Gábor Papp and Edit Fiák and Eszter Gáspár-Kiss and Bianka Perge and Nikolett Farmasi and Tünde Tarr},
  year = {2024},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines12030530},
  url = {https://doi.org/10.3390/biomedicines12030530}
}

RIS

TY  - JOUR
TI  - Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus
AU  - Nikolett Nagy
AU  - Bernadett Bói
AU  - Gábor Papp
AU  - Edit Fiák
AU  - Eszter Gáspár-Kiss
AU  - Bianka Perge
AU  - Nikolett Farmasi
AU  - Tünde Tarr
PY  - 2024
JO  - Biomedicines
DO  - 10.3390/biomedicines12030530
UR  - https://doi.org/10.3390/biomedicines12030530
ER  - 

APA

Nagy, N., Bói, B., Papp, G., Fiák, E., Gáspár-Kiss, E., Perge, B., Farmasi, N., & Tarr, T. (2024). Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus. Biomedicines. https://doi.org/10.3390/biomedicines12030530

Source records